SCHEMBL30783472

SCHEMBL30783472

CCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H](N)CCCCNC(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NOD1 Q9Y239 5/20 0.48
▸ TDP1 Q9NUW8 5/20 0.46
▸ ATM Q13315 2/20 0.46
▸ POLB P06746 3/20 0.45
▸ NPSR1 Q6W5P4 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ DPP7 Q9UHL4 1/20 0.44
▸ MAPT P10636 2/20 0.43
▸ GNAI3 P08754 1/20 0.43
▸ GNAO1 P09471 1/20 0.43
▸ GNAI1 P63096 1/20 0.43
▸ CAPN1 P07384 1/20 0.43
▸ SIRT2 Q8IXJ6 2/20 0.41
▸ CTSS P25774 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27261378 1.00 NOD1 (0.48) NOD1TDP1ATMPOLBNPSR1
SCHEMBL15706327 0.93 NPSR1 (0.51) NOD1TDP1ATMPOLBNPSR1
SCHEMBL15706357 0.93 NPSR1 (0.51) NOD1TDP1ATMPOLBNPSR1
SCHEMBL30019660 0.91 NOD1 (0.50) NOD1DPP7GNAI3GNAO1GNAI1
SCHEMBL15706349 0.91 POLB (0.49) NOD1TDP1ATMPOLBNPSR1
SCHEMBL27148691 0.88 NOD1 (0.49) NOD1DPP7GNAI3GNAO1GNAI1
SCHEMBL30020885 0.87 GNAI3 (0.57) NOD1TDP1MEN1KMT2ADPP7
SCHEMBL30020812 0.86 GLP1R (0.46) NOD1DPP7GNAI3GNAO1GNAI1
SCHEMBL30020169 0.85 NOD1 (0.49) NOD1DPP7GNAI3GNAO1GNAI1
SCHEMBL30783499 0.85 TDP1 (0.51) TDP1ATMPOLBNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4561998-A1 FIBROBLAST ACTIVATION PROTEIN-TARGETED COMPOSITIONS AND METHODS OF USE THEREOF Ratio Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2025029608-A1 FIBROBLAST ACTIVATION PROTEIN-TARGETED COMPOSITIONS AND METHODS OF USE THEREOF RATIO THERAPEUTICS, INC. (US) 2025-02-06 — — WO disclosed
WO-2024026072-A1 FIBROBLAST ACTIVATION PROTEIN-TARGETED COMPOSITIONS AND METHODS OF USE THEREOF RATIO THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback